Evidence map›Paper›PMID 37017526›Full record

ArticlemBio2023

Structural Basis of Dual Specificity of Sinorhizobium meliloti Clr, a cAMP and cGMP Receptor Protein.

Laura Werel, Neda Farmani, Elizaveta Krol, Javier Serrania, Lars-Oliver Essen, Anke Becker

Open access · goldAbstract read
In one paragraph

Article in mBio, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Laura Werel *Department of Chemistry, Philipps-Universität Marburg, Marburg, Germany.
Neda Farmani *Department of Biology, Philipps-Universität Marburg, Marburg, Germany.
Elizaveta KrolDepartment of Biology, Philipps-Universität Marburg, Marburg, Germany.
Javier SerraniaDepartment of Biology, Philipps-Universität Marburg, Marburg, Germany.
Lars-Oliver EssenDepartment of Chemistry, Philipps-Universität Marburg, Marburg, Germany.ORCID 0000-0003-4272-4026
Anke BeckerDepartment of Biology, Philipps-Universität Marburg, Marburg, Germany.ORCID 0000-0003-4561-9184
Philipps University of Marburg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In bacteria, the most prevalent receptor proteins of 3',5'-cyclic AMP (cAMP) and 3',5'-cyclic GMP (cGMP) are found among transcription factors of the Crp-Fnr superfamily. The prototypic Escherichia coli catabolite activator protein (CAP) represents the main Crp cluster of this superfamily and is known to bind cAMP and cGMP but to mediate transcription activation only in its cAMP-bound state. In contrast, both cyclic nucleotides mediate transcription activation by Sinorhizobium meliloti Clr, mapping to cluster G of Crp-like proteins. We present crystal structures of Clr-cAMP and Clr-cGMP bound to the core motif of the palindromic Clr DNA binding site (CBS). We show that both cyclic nucleotides shift ternary Clr-cNMP-CBS-DNA complexes (where cNMP is cyclic nucleotide monophosphate) to almost identical active conformations, unlike the situation known for the E. coli CAP-cNMP complex. Isothermal titration calorimetry measured similar affinities of cAMP and cGMP binding to Clr in the presence of CBS core motif DNA (equilibrium dissociation constant for cNMP (

Indexed as

Cyclic AMPSinorhizobium melilotiCarrier ProteinsCyclic AMP Receptor ProteinCyclic GMPDNAEscherichia coliCarrier ProteinsCyclic AMPCyclic AMP Receptor ProteinCyclic GMPDNAallosteric controlClr regulonCRP-like protein familynucleotide second messengerroot nodule symbiosis

Identifiers

PMID37017526
PMCPMC10127613
OpenAlexW4362601470

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.